N V Jacobus

4.7k total citations · 1 hit paper
75 papers, 3.7k citations indexed

About

N V Jacobus is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, N V Jacobus has authored 75 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Medicine, 40 papers in Clinical Biochemistry and 29 papers in Infectious Diseases. Recurrent topics in N V Jacobus's work include Antibiotic Resistance in Bacteria (45 papers), Bacterial Identification and Susceptibility Testing (40 papers) and Antibiotics Pharmacokinetics and Efficacy (26 papers). N V Jacobus is often cited by papers focused on Antibiotic Resistance in Bacteria (45 papers), Bacterial Identification and Susceptibility Testing (40 papers) and Antibiotics Pharmacokinetics and Efficacy (26 papers). N V Jacobus collaborates with scholars based in United States, Netherlands and Canada. N V Jacobus's co-authors include S. L. Gorbach, Francis P. Tally, David R. Snydman, L. A. McDermott, Peter J. Petersen, Carl F. Deneke, Michael Barza, R. T. TESTA, Jason Weiss and Phaik‐Eng Sum and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

N V Jacobus

75 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial substance from a human Lactobacillus strain

1987 437 citations N V Jacobus, S. L. Gorbach et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by N V Jacobus

Since Specialization

Citations

This map shows the geographic impact of N V Jacobus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N V Jacobus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N V Jacobus more than expected).

Fields of papers citing papers by N V Jacobus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N V Jacobus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N V Jacobus. The network helps show where N V Jacobus may publish in the future.

Co-authorship network of co-authors of N V Jacobus

This figure shows the co-authorship network connecting the top 25 collaborators of N V Jacobus. A scholar is included among the top collaborators of N V Jacobus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N V Jacobus. N V Jacobus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in the antibiotic susceptibility of anaerobic bacteria from 2007–2009 to 2010–2012 based on the CLSI methodology 2016 ·Anaerobe ·Christine J. Hastey, (unknown), Audrey N. Schuetz, Karen Anderson, Diane M. Citron, (unknown), Meredith Hackel, David W. Hecht, N V Jacobus, Stephen G. Jenkins, Maria Karlsson, C C Knapp, Laura Koeth, Hannah M. Wexler, (unknown)	39
2	Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009 2016 ·Anaerobe ·David R. Snydman, N V Jacobus, L. A. McDermott, Ellie J. C. Goldstein, Lizzie J. Harrell, Stephen G. Jenkins, Duane W. Newton, Robin Patel, D. W. Hecht	51
3	Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009 2011 ·Anaerobe ·David R. Snydman, N V Jacobus, L. A. McDermott, Yoav Golan, Ellie J. C. Goldstein, Lizzie J. Harrell, Stephen G. Jenkins, Duane W. Newton, C. Pierson, Jon E. Rosenblatt, Richard A. Venezia, S. L. Gorbach, Anne Marie Queenan, D. W. Hecht	75
4	Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007) 2010 ·Clinical Infectious Diseases ·David R. Snydman, N V Jacobus, (unknown), Yoav Golan, David W. Hecht, Ellie J. C. Goldstein, Lizzie J. Harrell, Stephen G. Jenkins, Duane W. Newton, Carl L. Pierson, John D. Rihs, Victor L. Yu, Richard A. Venezia, Sydney M. Finegold, Jon E. Rosenblatt, Sherwood L. Gorbach	110
5	In Vitro Activity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates 2010 ·Antimicrobial Agents and Chemotherapy ·David R. Snydman, N V Jacobus, L. A. McDermott	19
6	Evaluation of In Vitro Interaction of Daptomycin with Gentamicin or Beta-lactam Antibiotics Against taphylococcus aureus and Enterococci by FIC Index and Timed-Kill Curves 2005 ·Journal of Chemotherapy ·David R. Snydman, L. A. McDermott, N V Jacobus	41
7	Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group 2005 ·Journal of Antimicrobial Chemotherapy ·David R. Snydman, N V Jacobus, L. A. McDermott	7
8	National Survey on the Susceptibility ofBacteroides fragilisGroup: Report and Analysis of Trends for 1997–2000 2002 ·Clinical Infectious Diseases ·David R. Snydman, N V Jacobus, (unknown), Robin Ruthazer, E. J. C. Goldstein, S M Finegold, Lizzie J. Harrell, D. W. Hecht, Stephen G. Jenkins, C. Pierson, Richard A. Venezia, John D. Rihs, S. L. Gorbach	74
9	Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens 2000 ·Antimicrobial Agents and Chemotherapy ·David R. Snydman, N V Jacobus, L. A. McDermott, John R. Lonks, John M. Boyce	88
10	In vitro activity of piperacillin/tazobactam against isolates from patients enrolled in clinical trials 1996 ·International Journal of Antimicrobial Agents ·N. A. KUCK, N V Jacobus, Michael D. Spengler, Raymond T. Testa	7
11	Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines 1995 ·Journal of Antimicrobial Chemotherapy ·Jason Weiss, N V Jacobus, Peter J. Petersen, Raymond T. Testa	17
12	Glycothiohexides, novel antibiotics produced by "Sebekia" sp. I.-14E605. L Taxonomy, fermentation and biological evaluation. 1994 ·The Journal of Antibiotics ·D. A. Steinberg, Valerie S. Bernan, (unknown), (unknown), Cedric J. Pearce, J. D. KORSHALLA, N V Jacobus, P. J. Petersen, (unknown), William M. Maiese, (unknown)	15
13	Susceptibility of Anaerobes in Phase 3 Clinical Studies of Piperacillin/Tazobactam 1993 ·Clinical Infectious Diseases ·N V Jacobus, Fred Immermann, (unknown), R. T. TESTA	9
14	The antimicrobial susceptibility patterns of the Barteroides fragilis group in the United States, 1987 1990 ·Journal of Antimicrobial Chemotherapy ·Nancy A. Cornick, G J Cuchural, David R. Snydman, N V Jacobus, Paul B. Iannini, Gale B. Hill, Timothy J. Cleary, J. Paul O'Keefe, C. Pierson, S M Finegold	48
15	Colonization resistance of the human intestinal microflora: Testing the hypothesis in normal volunteers 1988 ·European Journal of Clinical Microbiology & Infectious Diseases ·S. L. Gorbach, Michael Barza, Marina Giuliano, N V Jacobus	43
16	A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections 1988 ·Journal of Oral and Maxillofacial Surgery ·William Gilmore, N V Jacobus, S. L. Gorbach, H.Chris Doku, Francis P. Tally	60
17	In vitro activity of LY146032 against gram-positive bacteria 1988 ·Diagnostic Microbiology and Infectious Disease ·(unknown), N V Jacobus, S. L. Gorbach	12
18	Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model 1987 ·Journal of Antimicrobial Chemotherapy ·(unknown), N V Jacobus, (unknown)	1
19	Activity of cefmetazole against anaerobic bacteria 1987 ·Antimicrobial Agents and Chemotherapy ·Nancy A. Cornick, N V Jacobus, S. L. Gorbach	12
20	Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins 1975 ·Antimicrobial Agents and Chemotherapy ·Francis P. Tally, N V Jacobus, John G. Bartlett, Sherwood L. Gorbach	118

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact